Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lenihan

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
The Oncologist|May 9, 2019
Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast CancerGiuseppe Curigliano, Evandro de Azambuja, Daniel Lenihan, et al.
Circulation|March 2, 2016
Cardiovascular Complications of Novel Multiple Myeloma TreatmentsWeijuan Li, R Frank Cornell, Daniel Lenihan, et al.
The American Journal of the Medical Sciences|January 19, 2013
Intracardiac thrombus: diagnosis, complications and managementUgochukwu O Egolum, Daniel G Stover, Ryan Anthony, et al.
Cardio-Oncology (London, England)|September 28, 2024
How to utilize current guidelines to manage patients with cancer at high risk for heart failureMichelle Bloom, Jose A Alvarez-Cardona, Sarju Ganatra, et al.
The American Journal of the Medical Sciences|February 11, 2014
Is a palpable pulse always restored during cardiopulmonary resuscitation in a patient with a left ventricular assist device?Nicholas A Haglund, Kelly Schlendorf, Mary Keebler, et al.
Open Heart|January 27, 2017
Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT studyHari K Narayan, Wei Wei, Ziding Feng, et al.
Cardio-Oncology (London, England)|April 23, 2026
Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategiesSimona Chiusolo, Chelsea Kriesberg, Eric Oligino, et al.
The Oncologist|July 30, 2025
Considerations for the Practical Management of Cardiovascular Risk With Bruton's Tyrosine Kinase Inhibitors for Patients With CLLDaniel Lenihan, Michelle Bloom, Robert Copeland-Halperin, et al.
International Journal of Molecular Sciences|July 27, 2024
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple MyelomaMarwa Tantawy, Taimour Langaee, Danxin Wang, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|April 26, 2019
Feasibility and Outcomes of an Exercise Intervention for Chemotherapy-Induced Heart FailureEdward Tsai, Elie Mouhayar, Daniel Lenihan, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
The Oncologist|May 9, 2019
Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast CancerGiuseppe Curigliano, Evandro de Azambuja, Daniel Lenihan, et al.
Circulation|March 2, 2016
Cardiovascular Complications of Novel Multiple Myeloma TreatmentsWeijuan Li, R Frank Cornell, Daniel Lenihan, et al.
The American Journal of the Medical Sciences|January 19, 2013
Intracardiac thrombus: diagnosis, complications and managementUgochukwu O Egolum, Daniel G Stover, Ryan Anthony, et al.
Cardio-Oncology (London, England)|September 28, 2024
How to utilize current guidelines to manage patients with cancer at high risk for heart failureMichelle Bloom, Jose A Alvarez-Cardona, Sarju Ganatra, et al.
The American Journal of the Medical Sciences|February 11, 2014
Is a palpable pulse always restored during cardiopulmonary resuscitation in a patient with a left ventricular assist device?Nicholas A Haglund, Kelly Schlendorf, Mary Keebler, et al.
Open Heart|January 27, 2017
Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT studyHari K Narayan, Wei Wei, Ziding Feng, et al.
Cardio-Oncology (London, England)|April 23, 2026
Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategiesSimona Chiusolo, Chelsea Kriesberg, Eric Oligino, et al.
The Oncologist|July 30, 2025
Considerations for the Practical Management of Cardiovascular Risk With Bruton's Tyrosine Kinase Inhibitors for Patients With CLLDaniel Lenihan, Michelle Bloom, Robert Copeland-Halperin, et al.
International Journal of Molecular Sciences|July 27, 2024
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple MyelomaMarwa Tantawy, Taimour Langaee, Danxin Wang, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|April 26, 2019
Feasibility and Outcomes of an Exercise Intervention for Chemotherapy-Induced Heart FailureEdward Tsai, Elie Mouhayar, Daniel Lenihan, et al.
Pageof 8